Cargando…
LBODP046 Reduction In "Cardiovascular Death Or Hospitalisation For Heart Failure" With Sglt-2is Is Dependent On Weight Reduction: A Meta-regression Analysis
AIMS: The modern management of type 2 diabetes (T2D) has shifted focus from a "glucocentric" approach to one that focuses on outcomes reduction. As a result, the aim of management is skewed toward specific molecules like sodium glucose co-transporter 2 inhibitors (SGLT-2is) and glucagon-li...
Autores principales: | Ghosal, Samit, Sinha, Binayak, Kar, Partha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624776/ http://dx.doi.org/10.1210/jendso/bvac150.556 |
Ejemplares similares
-
LBODP062 SGLT2 Inhibition Ameliorates Cognitive And Physical Impairment In Patients With HFpEF And Diabetes
por: Mone, Pasquale, et al.
Publicado: (2022) -
LBODP041 Effects Of Sodium-glucose Co-transporter 2 Inhibitors (sglt-2 Inhibitors) On Adipokines And Inflammatory Biomarkers In Type2 Diabetic Patients
por: Kumtree, Phonphruet
Publicado: (2022) -
LBODP035 When Is Ketosis Just Ketosis?
por: Cannon, Sophie M, et al.
Publicado: (2022) -
LBODP033 The Compliant Patient - When Adherence Hurts
por: Cheah, Zhen Fung, et al.
Publicado: (2022) -
LBODP039 Glycogenic Hepatopathy- An Underrecognized Complication Of Diabetes
por: Chamakkala, Tess, et al.
Publicado: (2022)